Javad Shahidi
Senior Vice President, Biotech Unit BeOne Medicines
Dr. Javad Shahidi is a physician with a long track record in oncology drug development. For more than a decade, Dr. Shahidi has been leading the clinical development of multiple biologics including Antibody Drug Conjugates across various stages from pre-IND to global regulatory approvals. He currently serves as the Senior Vice President and Head of Biotech Unit at BeOne Medicines.
Seminars
Tuesday 24th February 2026
Panel Discussion: Evaluating the Cutting-Edge Innovation & Performance Driving ADC Differentiation & Progression Earlier Line Patient Therapies
8:00 am
- Understanding the 2026 ADC landscape and how the bar has been raised to develop and deliver differentiated ADCs with meaningful patient impact
- Assessing the need for novel ADC chemistry innovation: What is showing the most promise across novel payloads and conjugation technologies?
- Discussing the potential of novel ADC biology approaches across bispecific targeting and antibody engineering to unlock next generation ADC therapies
- Highlighting methods to best pursue ADC clinical differentiation across patient selections methods, combination strategies, and well executed clinical design
